Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Venus Medtech (Hangzhou) Inc. has announced its 2024 Second Extraordinary General Meeting, set to take place on December 5, 2024. Key resolutions include the election of Mr. John Junhua Gu as an independent non-executive director and proposed amendments to the company’s Articles of Association. Shareholders are encouraged to participate and vote on these significant decisions.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.